Shanghai researchers engineer biological pacemaker that could offer a new way to control abnormal heart rhythms Scientists in Shanghai have used stem cells to create the world's first laboratory-grown ...

PORTLAND, Ore (KOIN) – On behalf of our sponsors at Abbott, we’re learning about how a medical breakthrough is transforming the way we treat abnormal heart rhythms and one Boston mother’s story shows ...

The FDA has approved Abbott Laboratories' ABT AVEIR dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system to treat abnormal or slow heart rhythms. Through ...

Deep within the heart’s right atrium lies the sinoatrial node, a tiny cluster of ...

Having an accelerated junctional rhythm occurs when the atrioventricular node in your heart beats too quickly. It happens as a result of damage to your heart’s primary natural pacemaker. There’s no ...

Chinese scientists have successfully grown the world's first sinoatrial node organoid from stem cells, offering a potential ...

Last week, Abbott began the commercial launch of its new leadless pacemaker, which it believes is a historic development in the world of cardiac rhythm devices. Aveir DR is a better option than ...

A new leadless dual-chamber pacemaker for patients with heart issues could be available later this year, according to new research published last week and funded by Abbott Medical. The U.S. Food and ...

Northwestern University engineers have developed a pacemaker so tiny that it can fit inside the tip of a syringe—and be noninvasively injected into the body. Although it can work with hearts of all ...

ABBOTT PARK, Ill., Nov. 12, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced new, late-breaking data from the global Leadless II IDE study evaluating Abbott's investigational Aveir leadless ...

The heart may be small, but its rhythm powers life. When something throws that rhythm off—especially after surgery—it can become a race against time to restore balance. For decades, doctors have ...